Cargando…

Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies

OBJECTIVE: Mucosal healing (MH) is an important treatment goal in patients with inflammatory bowel disease (IBD), but factors predicting MH under medical therapy are largely unknown. In this study, we aimed to characterize predictive factors for MH in anti-TNF-alpha antibody-treated IBD patients. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Beigel, Florian, Deml, Matthias, Schnitzler, Fabian, Breiteneicher, Simone, Göke, Burkhard, Ochsenkühn, Thomas, Brand, Stephan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059645/ https://www.ncbi.nlm.nih.gov/pubmed/24932476 http://dx.doi.org/10.1371/journal.pone.0099293

Ejemplares similares

Analysis of IL12B Gene Variants in Inflammatory Bowel Disease
por: Glas, Jürgen, et al.
Publicado: (2012)

CEACAM6 Gene Variants in Inflammatory Bowel Disease
por: Glas, Jürgen, et al.
Publicado: (2011)

The NOD2 Single Nucleotide Polymorphism rs72796353 (IVS4+10 A>C) Is a Predictor for Perianal Fistulas in Patients with Crohn's Disease in the Absence of Other NOD2 Mutations
por: Schnitzler, Fabian, et al.
Publicado: (2015)

The NOD2 p.Leu1007fsX1008 Mutation (rs2066847) Is a Stronger Predictor of the Clinical Course of Crohn's Disease than the FOXO3A Intron Variant rs12212067
por: Schnitzler, Fabian, et al.
Publicado: (2014)

Oncostatin M Mediates STAT3-Dependent Intestinal Epithelial Restitution via Increased Cell Proliferation, Decreased Apoptosis and Upregulation of SERPIN Family Members
por: Beigel, Florian, et al.
Publicado: (2014)

The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn's Disease
por: Storr, Martin, et al.
Publicado: (2010)

Solid Organ Transplantation in Patients with Inflammatory Bowel Diseases (IBD): Analysis of Transplantation Outcome and IBD Activity in a Large Single Center Cohort
por: Schnitzler, Fabian, et al.
Publicado: (2015)

The NOD2 Single Nucleotide Polymorphisms rs2066843 and rs2076756 Are Novel and Common Crohn's Disease Susceptibility Gene Variants
por: Glas, Jürgen, et al.
Publicado: (2010)

IRGM Variants and Susceptibility to Inflammatory Bowel Disease in the German Population
por: Glas, Jürgen, et al.
Publicado: (2013)

Evidence for STAT4 as a Common Autoimmune Gene: rs7574865 Is Associated with Colonic Crohn's Disease and Early Disease Onset
por: Glas, Jürgen, et al.
Publicado: (2010)

PTPN2 Gene Variants Are Associated with Susceptibility to Both Crohn's Disease and Ulcerative Colitis Supporting a Common Genetic Disease Background
por: Glas, Jürgen, et al.
Publicado: (2012)

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression
por: Stallhofer, Johannes, et al.
Publicado: (2022)

Comparative Analysis of the Lambda-Interferons IL-28A and IL-29 regarding Their Transcriptome and Their Antiviral Properties against Hepatitis C Virus
por: Diegelmann, Julia, et al.
Publicado: (2010)

Leucine-rich alpha-2 glycoprotein as a marker of mucosal healing in inflammatory bowel disease
por: Yasutomi, Eriko, et al.
Publicado: (2021)

Efficiency of Orexin-A for Inflammatory Flare and Mucosal Healing in Experimental Colitis: Comparison with the Anti-TNF Alpha Infliximab
por: Blais, Anne, et al.
Publicado: (2023)

NOD/scid IL‐2Rγ(null) mice reconstituted with peripheral blood mononuclear cells from patients with Crohn's disease reflect the human pathological phenotype
por: Unterweger, Anna‐Lena, et al.
Publicado: (2021)

The Combination of Patient Profiling and Preclinical Studies in a Mouse Model Based on NOD/Scid IL2Rγ (null) Mice Reconstituted With Peripheral Blood Mononuclear Cells From Patients With Ulcerative Colitis May Lead to Stratification of Patients for Treatment With Adalimumab
por: Jodeleit, Henrika, et al.
Publicado: (2020)

Biochemical Biomarkers of Mucosal Healing for Inflammatory Bowel Disease in Adults
por: Krzystek-Korpacka, Małgorzata, et al.
Publicado: (2020)

Head-to-head study of oxelumab and adalimumab in a mouse model of ulcerative colitis based on NOD/Scid IL2Rγ(null) mice reconstituted with human peripheral blood mononuclear cells
por: Jodeleit, Henrika, et al.
Publicado: (2021)

Mucosal healing and inflammatory bowel disease: Therapeutic implications and new targets
por: Otte, Megan Lynn, et al.
Publicado: (2023)

Development of a uniform, very aggressive disease phenotype in all homozygous carriers of the NOD2 mutation p.Leu1007fsX1008 with Crohn’s disease and active smoking status resulting in ileal stenosis requiring surgery
por: Schnitzler, Fabian, et al.
Publicado: (2020)

A nanoparticle platform for combined mucosal healing and immunomodulation in inflammatory bowel disease treatment
por: Marotti, Valentina, et al.
Publicado: (2023)

Editorial: Immune-Epithelial Crosstalk in Inflammatory Bowel Diseases and Mucosal Wound Healing
por: Leppkes, Moritz, et al.
Publicado: (2018)

Surrogate markers of mucosal healing in inflammatory bowel disease: A systematic review
por: State, Monica, et al.
Publicado: (2021)

Comparison of transmural healing and mucosal healing as predictors of positive long-term outcomes in Crohn’s disease
por: Ma, Li, et al.
Publicado: (2021)

Anti-TNF-α Therapy Suppresses Proinflammatory Activities of Mucosal Neutrophils in Inflammatory Bowel Disease
por: Zhang, Cui, et al.
Publicado: (2018)

Mucosal gene expression changes induced by anti‐TNF treatment in inflammatory bowel disease patients
por: Milanesi, Elena, et al.
Publicado: (2019)

Influence of antiTNF-alpha antibody treatment on fracture healing under chronic inflammation
por: Timmen, Melanie, et al.
Publicado: (2014)

Early Start of Infliximab in Crohn’s Disease Increases Rates of Endoscopic Remission and Decreases Stenosis Formation: Experiences From a Single Center Cohort
por: Schnitzler, Fabian, et al.
Publicado: (2021)

Association of sleep quality and mucosal healing in patients with inflammatory bowel disease in clinical remission
por: Michalopoulos, George, et al.
Publicado: (2018)

Systemic interleukin-9 in inflammatory bowel disease: Association with mucosal healing in ulcerative colitis
por: Matusiewicz, Malgorzata, et al.
Publicado: (2017)

Achieving Mucosal Healing in Inflammatory Bowel Diseases: Which Drug Concentrations Need to Be Targeted?
por: Van den Berghe, Nathalie, et al.
Publicado: (2019)

An Improved Score for the Evaluation of Mucosal Healing in Inflammatory Bowel Disease—A Pilot Study
por: Neamți, Lidia, et al.
Publicado: (2023)

TNF-Alpha Gene Polymorphisms in Iranian Azari Turkish Patients with Inflammatory Bowel Diseases
por: Bonyadi, Mortaza, et al.
Publicado: (2014)

Leucine-rich Alpha-2 Glycoprotein is a Serum Biomarker of Mucosal Healing in Ulcerative Colitis
por: Shinzaki, Shinichiro, et al.
Publicado: (2017)

Reclassifying Pseudopolyps in Inflammatory Bowel Disease: Histologic and Endoscopic Description in the New Era of Mucosal Healing
por: Rezapour, Mona, et al.
Publicado: (2019)

Faecal Calprotectin in Assessment of Mucosal Healing in Adults with Inflammatory Bowel Disease: A Meta-Analysis
por: Bromke, Mariusz A., et al.
Publicado: (2021)

Higher Adalimumab Trough Levels Are Associated with Histologic Remission and Mucosal Healing in Inflammatory Bowel Disease
por: Wong, Rochelle, et al.
Publicado: (2023)

Prothrombotic effects of tumor necrosis factor alpha in vivo are amplified by the absence of TNF-alpha receptor subtype 1 and require TNF-alpha receptor subtype 2
por: Pircher, Joachim, et al.
Publicado: (2012)

Raman spectroscopy accurately differentiates mucosal healing from non-healing and biochemical changes following biological therapy in inflammatory bowel disease
por: Smith, Samuel C. L., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_r68d0o179vt39knpn7he79mhoa